Vox Sanguinis

Article	Citations
Issue Information	30
Issue Information	26
	22
Cord blood freezing bag breakage at transplant centres: Low breakage rate in Japan	21
Evaluation of bleed duration and adverse donor reactions during the blood donation process	19
Events	17
Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease	16
Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis	15
A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion	15
Issue Information	15
Issue Information	15
Supplying whole blood with drones for prehospital transfusion at trauma sites in Finland: A simulation	15
Transfusion‐associated acute lung injury following albumin treatment in liver disease	15
Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan	14
A novel syphilis Treponema pallidum lipoprotein peptide antigen diagnostic assay using red cell kodecytes in routine blood centre column agglutination testing platforms	14
The prototypical UK blood donor, homophily and blood donation: Blood donors are like you, not me	14
Reported non‐compliance with pre‐donation screening among blood donors in Québec, Canada: A focus on the 3‐month deferral for men who have sex with men	14
Issue Information	14
West Nile and Usutu viruses are efficiently inactivated in platelet concentrates by UVC light using the THERAFLEX UV‐Platelets system	13
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France	13
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays	13
Evaluation of immunoglobulin replacement therapy in secondary immunodeficiency at three British Columbia hospitals	12
Issue Information	12
Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence	12
RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study	11

Development of an in‐house bone marrow collection kit: The Catalan bone marrow transplantation group experience	11
Non‐neutralizing antibody profiles against hepatitis B virus: A comparative study of Japanese‐ and US‐donor‐derived intramuscular human hepatitis B‐specific immunoglobulin preparations	11
Voluntary blood donation preferences in China: A discrete choice experiment among experienced and inexperienced donors	10
	10
Events	10
	10
Notification of blood donors who test positive for transfusion‐transmissible infections	10
Events	10
Corrigendum	10
Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients	10
In vitro quality assessment of red blood cells and plasma units in DEHT / SAGM bags and	9
Impact of restrictive red blood cell transfusion strategy on thrombosis‐related events: A meta‐analysis and systematic review	9
Events	9
Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies	9
Issue Information	9
Research partnerships between blood services and public health authorities: An international, cross‐sectional survey	9
Low‐dose prophylaxis and its impact on the health of haemophilia patients	9
Parents' perception and knowledge regarding blood transfusion in a tertiary care paediatric centre in India	9
Has the switch to sexual risk behaviour screening impacted deferrals for pre‐ and post‐exposure prophylaxis therapy for human immunodeficiency virus?	9
Deferral of blood donors who have ever stayed in a Trypanosoma cruzi endemic area: An international survey	9
Impact of conflict/war disasters on blood banks and transfusion services in low‐ and middle‐income countries in the Eastern Mediterranean region	9
Virtual platelet cross‐matching as transfusion management for patients with immune platelet refractoriness	9
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries	8
	8
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance	8
Events	8
Plasma transfusion practices: A multicentre electronic audit	8
Re‐evaluating treatment thresholds in patient blood management: Female patients experience more perioperative anaemia and higher transfusion rates in major elective surgery	8
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral	7
International Forum on Transfusion Education for Healthcare Professionals Who Administer Blood to Patients in Hospitals and Health Services: Summary	7
Identification of a novel variant c.761C>T onABO*B.01gene in ABO glycosyltransferases associated with Bweakphenotype	7
Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major	7
The role of CD36 antibodies in haematopoietic stem cell transplantation	7
Proof of concept for detection of staphylococcal enterotoxins in platelet concentrates as a novel safety mitigation strategy	7
Issue Information	7
Successful implementation of a patient blood management programme in a lower middle‐income state	7
Characterization of transfusion‐relevant bacteria reference strains in a lyophilized format	7
Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape	7
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry	7
Issue Information	6
Issue Information	6
Issue Information	6
Standardized electronic messages to enhance communication in transfusion and transplantation	6
Events	6
Is it time for the death knell of single‐unit plasma?	6
Use of O RhD‐negative red blood cells: A nationwide, prospective audit	6
Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil , 2019–2021	6
Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretation	6
Events	6
Beyond transfusion: Platelet‐derived therapeutic products as a new frontier for blood establishments and transfusion medicine	6

Author Index	6
A norm for all seasons: Application of the ISO 14001 standard to manage the environmental impacts of transfusion	6
Alemtuzumab and autoimmune haemolytic anaemia: Coincidence or causation?	6
International Forum on Genotyping of Blood Antigens in Donors: Summary	6
In vitro comparison of cold‐stored whole blood and reconstituted whole blood	6
Events	6
Assessment of amino acids and metabolites in the supernatant of stored concentrates blood from sickle cell trait (SCT) and reference (non‐SCT) donors	6
Analysis of maternal Fc gamma receptor IIIb isoantibodies using immunomagnetic negative selected neutrophils	6
Ethnic diversity in Chilean blood groups: A comprehensive analysis of genotypes, phenotypes, alleles and the immunogenic potential of antigens in northern, southern and central regions	6
Evaluation of a method to fluorescently label platelets for in‐human recovery and survival studies	6
Molecular biology analysis of ABO blood group variants caused by natural chimaerism	6
Laboratory approach for vaccine‐induced thrombotic thrombocytopenia diagnosis in the Netherlands	6
Breast milk contains red cell isohaemagglutinins: An observational study of 176 mothers	6
The contemporary management of haemolytic disease of the fetus and newborn	5
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance	5
Enhanced O 2 availability in platelet concentrates stored for neonatal t	5
Events	5
Response of the Japanese Red Cross Blood Center in Ishikawa Prefecture to the 2024 Noto Peninsula earthquake	5
	5
	5
Can volume‐reduced plasma products prevent transfusion‐associated circulatory overload in a two‐hit animal model?	5
Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation	5
	5
Advancing resilience and sustainability in plasma collections and plasma‐derived medicinal product accessibility	5
Closed system production of serum eye drops using dockable saline	5
Issue Information	5
Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis	5
Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors	5
Meta‐analysis of efficacy and safety of pathogen‐reduced platelet components: Request for clarification	5
	5
Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors	5
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma	5
Tetanus antibodies in normal human immunoglobulin preparations	5
The association between attitude towards facemasks, quality of donation experience and relationship with healthcare providers: A cross‐sectional exploratory study	5
Screening, genotyping and haematological analysis of glucose‐6‐phosphate dehydrogenase deficiency in the blood donors of Wuxi City, China	5
Events	5
Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula	5
	5
International Society for Blood Transfusion Guidelines for Validation of Automated Systems in Blood Establishments	5
	5
Diary of Events	5
Evaluation of cell collection efficiency in non‐mobilized adult donors for autologous chimeric antigen receptor T‐cell manufacturing	5
Current state of gene therapy in sickle cell disease	5
Multinational transfusion practices and outcomes in haematology patients admitted to the intensive care unit	5
Characteristics of red blood cell transfusion among very preterm infants in China	5
Associated criteria used in investigating suspected septic transfusion reactions: A scoping review	4
Issue Information	4
Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura	4
	4
Analysis of wrong blood in tube events at a hospital‐based blood centre in a tertiary care referral hospital: A perspective from a lower middle‐income country	4
Onsite vasovagal reactions with and without loss of consciousness are distinct outcomes with different risk factors	4
A para‐Bombay phenotype due to compound heterozygosity involving a novel FUT1 variant	4
Issue Information	4
Transfusion‐related acute lung injury induced by human leucocyte antigen‐II antibodies: Analysis of antibody typing and source	4
The availability of plasma donors and plasma: A sociologist's perspective	4
Author Index	4
Development and validation of a scoring system to predict vasovagal reaction upon whole‐blood donation	4
Donors in the COVID‐19 era: How did donor characteristics change in Japan?	4
Issue Information	4
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study	4
The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves	4
The effect of near‐infrared low‐level light on the in vitro quality of platelets during storage	4
Diary of Events	4
Issue Information	4
Analysis of gender representation on transfusion medicine journal editorial boards: Comparison between 2019 and 2022	4
Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia	4
The impact of non‐disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms	4
The safety of pathogen‐reduced platelet transfusions in critically ill term and preterm neonates	4
Transfusion efficacy of leucoreduced packed red blood cells prepared by two different methods: A randomized controlled trial in transfusion‐dependent thalassaemia patients (FUEL trial)	4
Events	4
Incentives for plasma donation	4
A scoping review of grey zone use for transfusion‐transmitted infection screening among blood donors	4
Challenges in promoting stewardship of albumin: A comparative perspective from recent guidelines	4
Issue Information	4
Issue Information	4
Hepatitis B virus genotype surveillance in Canadian blood donors and a referred patient population, 2016–2021	4
RHDalleles contributing to serologically weak D phenotypes in China: A single‐centre study over 10 years	4
	3
HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)	3
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply	3

Paediatric clinical decision support: Evaluation of a best practice alert for red blood cell transfusion	3
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial	3
The importance of confirmatory assays in testing blood donors for human T‐cell lymphotropic virus	3
Facilitators of and barriers to blood donation among voluntary non‐remunerated blood donors in sub‐Saharan Africa: A scoping review	3
A retrospective analysis of postpartum red blood cell transfusions at a tertiary care obstetric centre	3
Rapid genotyping of 508G>A (rs3745635) and 1067T>A (rs3894326) of FUT3 by a duplex Eprobe‐mediated melting curve analysis	3
	3
International Forum on Management of Blood Donors with Culture‐Positive Platelet Donations: Responses	3
Cold storage alters the immune characteristics of platelets and potentiates bacterial‐induced aggregation	3
Using competition for plasma donor recruitment and retention: An Australian university case study	3
Cryopreserved platelets washed with a dialysis machine for dimethyl sulphoxide removal	3
Determination of CD177 (human neutrophil antigen 2) polymorphisms using nanopore sequencing	3
Diary of Events	3
Contemporary patient blood management in abnormally invasive placenta at a tertiary centre, with a focus on the role of the transfusion practitioner	3
Issue Information	3
Blood transfusion is associated with increased mortality for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation support	3
Use of selective phenotyping and genotyping to identify rare blood donors in Canada	3
Blood collection technique and processing impact the nucleosomes and complement contents of platelet products	3
Impact of the pathogen inactivation process on the migration of di(2‐ethylhexyl) phthalate from plasma bags	3
Validation of a flow‐cytometry‐based red blood cell antigen phenotyping method	3
Influence of donor age, sex and ethnicity on high‐titre anti‐A and ‐B: Review of 6 million donations from two national blood providers	3
A comprehensive approach to continuous quality improvement of massive transfusion by developing key performance indicators	3
The selection and preparation of red cell components for intrauterine transfusion: A national survey	3
Issue Information	3
A questionnaire‐based survey on conversion from whole blood to apheresis donations among group AB donors in Hong Kong	3
Simulated effects of ferritin screening on C‐reactive protein levels in recruited blood donors	3
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic	3
Comparison of automated versus semi‐automated whole blood processing systems: A systematic review	3
	3
Management of blood transfusion services in low‐resource countries	3
Issue Information	3
Three buffy coat platelet concentrates: Use of data modelling to make more with less	3
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro	3
Therapeutic efficacy and safety of pathogen‐reduced platelet components: Results of a meta‐analysis of randomized controlled trials	3
Transfusion consent in Brazil: A nationwide survey of practices and form content	3
Platelets retain function and can be stored following disruption of human leucocyte antigens	3
Extending the post‐thaw shelf‐life of cryoprecipitate when stored at refrigerated temperatures	3
Bacterial screening of platelet components: Experience at a hospital‐based blood bank	3
Factors influencing transfusion reactions in paediatric patients: Active haemovigilance data from a children's hospital in India	3
Issue Information	3
Monitoring viral genomic sequences in transfusion‐transmitted viruses	3
Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations	3
Split red blood cell units contain defined extracellular K + levels, which are improved by a washing procedure	3
Comparative evaluation of efficacy and safety of automated versus manual red cell exchange in sickle cell disease: A systematic review and meta‐analysis	3
Detecting serologically difficult ABO blood groups using single‐molecule real‐time sequencing technology	3
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems	3
Can reactive donor screening results be presumed false positive following unstandardized testing procedures?	3
A congress report of the new Emerging Pathogens and Parasitology Subgroup within the ISBT Working Party on Transfusion‐Transmitted Infectious Disease	3
Prevalence of adsorbed A antigen onto donor‐derived group O red cells in children following stem cell transplantation: A single‐centre evaluation	3
Safeguarding plasma for fractionation: How can we deal with operational challenges in European Union countries	3
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies	3